Immune mediation of hypersensitivity adverse drug reactions: implications for therapy

HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz

(2009) Zulma G Vitezica et al.   AIDS

The roles of drug metabolism in the pathogenesis of T-cell-mediated drug hypersensitivity

(2009) Sidonie Nelly Lavergne et al.   Current Opinion in Allergy and Clinical Immunology

The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV

(2008) Bruce R Schackman et al.   AIDS

Association of Fas Ligand gene polymorphism with Stevens-Johnson syndrome

(2008) M Ueta et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Demonstration of the Metabolic Pathway Responsible for Nevirapine-Induced Skin Rash

(2008) Jie Chen et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Hypersensitivity to local anaesthetics - update and proposal of evaluation algorithm

(2008) Jacob Pontoppidan Thyssen et al.   CONTACT DERMATITIS

Antibiotic allergy: Immunochemical and clinical considerations

(2008) Brian A. Baldo et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Skin Tests in the Diagnosis of Drug Hypersensitivity Reactions

(2008) Knut Brockow et al.   CURRENT PHARMACEUTICAL DESIGN

Changes in Gene Expression Induced by Carbamazepine and Phenytoin: Testing the Danger Hypothesis

(2008) Wei Lu et al.   Journal of Immunotoxicology

HLA-B*5701 Screening for Hypersensitivity to Abacavir

(2008) Simon Mallal et al.   NEW ENGLAND JOURNAL OF MEDICINE

A European study of HLA-B in Stevens???Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

(2008) Christine Lonjou et al.   Pharmacogenetics and Genomics

Idiosyncratic Drug Reactions: Past, Present, and Future

(2007) Jack Uetrecht   CHEMICAL RESEARCH IN TOXICOLOGY